Clinical Trials Browser

Burkitt Lymphoma, Carcinoma, Renal Cell, Esophageal Neoplasms, Glioma, Carcinoma, Hepatocellular, Leukemia, Myeloid, Lung Neoplasms, Lymphoma, Melanoma, Mesothelioma, Multiple Myeloma, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Sarcoma, Synovial, Colorectal Neoplasms

NCT03699332 2019-09-13

MMIPC

Phase 1/2 Unknown

29 enrolled

GastrointestinalGynecologic

Carcinoma, Gastrointestinal Neoplasms, Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms

NCT04008511 2019-07-05

Regorafenib and XELOX as 2nd Line Treatment in Metastatic Colorectal Cancer

Phase 1/2 Unknown

54 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT03904537 2019-04-05

A Study of Combination of Anti-PD1 Antibody-activated TILs and Chemotherapy in Colorectal Cancer

Phase 1/2 Unknown

20 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT02450656 2018-08-27

M14AFS

Phase 1/2 Unknown

320 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT00159484 2017-06-27

Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer

Phase 1/2 Unknown

75 enrolled

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT03076957 2017-03-10

A Phase 1/2a Study to Assess the Safety and Efficacy of CKD-516 Tab. in Combination With Irinotecan Inj.

Phase 1/2 Unknown

24 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT03047525 2017-02-09

Study of DC-CTL Combined With CIK for Advanced Solid Tumor

Phase 1/2 Unknown

200 enrolled

GastrointestinalGenitourinaryHead & NeckThoracic

Nasopharyngeal Carcinoma, Carcinoma, Renal Cell, Lung Neoplasms, Colorectal Neoplasms

NCT02617134 2016-12-06

CAR-T Cell Immunotherapy in MUC1 Positive Solid Tumor

Phase 1/2 Unknown

20 enrolled

Gastrointestinal

Stomach Neoplasms, Colorectal Neoplasms

NCT02839954 2016-12-06

CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor

Phase 1/2 Unknown

10 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT02886897 2016-09-01

A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors

Phase 1/2 Unknown

50 enrolled

BreastGastrointestinalGenitourinaryThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Colorectal Neoplasms

NCT02781155 2016-05-24

Limiting Chemotherapy Side Effects by Using Moxa

Phase 1/2 Unknown

25 enrolled

BreastClassical hematologyGastrointestinal

Anemia, Breast Neoplasms, Genital Neoplasms, Female, Neoplasms, Neutropenia, Thrombocytopenia, Colorectal Neoplasms

NCT01626963 2016-03-24

Single-port Versus Conventional Laparoscopic Colorectal Surgery

Phase 1/2 Unknown

50 enrolled

Gastrointestinal

Diverticular Diseases, Colorectal Neoplasms, Inflammatory Bowel Diseases

NCT01882946 2015-10-07

Safety and Efficacy Study of DCVax-Direct in Solid Tumors

Phase 1/2 Unknown

60 enrolled

DermatologicGastrointestinal

Liver Neoplasms, Melanoma, Pancreatic Neoplasms, Colorectal Neoplasms

NCT02528526 2015-08-19

OXY1A

Phase 1/2 Unknown

69 enrolled

Gastrointestinal

Hypoxia, Liver Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT00553683 2014-01-14

Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer

Phase 1/2 Unknown

50 enrolled

BreastDermatologicGastrointestinalGynecologic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Colonic Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT00031616 2013-12-18

NB1011 in Treating Patients With Metastatic or Recurrent Colorectal Cancer

Phase 1/2 Unknown

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00007826 2013-09-20

Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer

Phase 1/2 Unknown

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01166035 2010-07-20

TEXO

Phase 1/2 Unknown

20 enrolled

GastrointestinalHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Colorectal Neoplasms

NCT00496704 2009-08-21

Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With Irinotecan

Phase 1/2 Unknown

56 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00478946 2009-01-21

A Study of Picoplatin in Colorectal Cancer

Phase 1/2 Unknown

43 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT00524706 2008-11-13

Phase I/II Study of SOL for Untreated Metastatic Colorectal Cancer

Phase 1/2 Unknown

42 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT00003001 2008-07-24

Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Phase 1/2 Unknown

63 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00154713 2005-09-12

Immunotherapy for Colorectal Cancers Using CEA-Pulsed Dendritic Cells and Subsequent IL-2 Treatment

Phase 1/2 Unknown

37 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT00057395 2005-06-24

A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies

Phase 1/2 Unknown

40 enrolled

GastrointestinalGynecologic

Esophageal Neoplasms, Carcinoma, Hepatocellular, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT00081536 2005-06-24

Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies

Phase 1/2 Unknown

105 enrolled

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

Clinical Trials

Dendritic Cell Vaccination in Patients With Lynch Syndrome or Colorectal Cancer With MSI

Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors

Safety and Efficacy of Fruquintinib+FOLFIRI in RAS-mutated Metastatic Colorectal Cancer

TAP-DEX

ALCAP

Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer

V-shoRT-R3

Efficacy, Tolerability and Safety of Intravenous D-VC With ATO in Patients With Advanced/Metastatic Colorectal Cancer

PA001

PIPAC for the Treatment of Colorectal Peritoneal Metastases

Fruquintinib Plus Capecitabine as Maintenance Treatment of RAS / BRAF Wild-type Metastatic Colorectal Cancer

Regorafenib Plus Raltitrexed as Third-line Treatment in Advanced Colorectal Cancer Patients

Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor

A Phase 2 Trial of SCO-101 in Combination With FOLFIRI for Patients With Metastatic Colorectal Cancer (mCRC) With Acquired Resistance to FOLFIRI

Toripalimab Plus Bevacizumab and Chemotherapy as Neoadjuvant Therapy in Advanced MSI-H or dMMR Colorectal Cancer

Neoadjuvant Electrochemotherapy for Colorectal Cancer - a Randomized Controlled Trial

Regorafenib Plus PD-1 Inhibitor in Patients With Colorectal Cancer

Modelle 001, TS-inhibition in Colorectal Liver Metastases Comparing Arfolitixorin and Calciumfolinate

A Clinical Study of Exploring Camrelizumab in the Treatment of Colorectal Mucinous Adenocarcinoma(MAC)

JS001 Combined With Regorafenib in Patients With Advanced Colorectal Cancer

A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal Cancer

A Trial of SHR-1210 in Combination With AIN457 in Patients With MSS CRC（SHR-1210-AIN457）

Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies

MMIPC

Regorafenib and XELOX as 2nd Line Treatment in Metastatic Colorectal Cancer

A Study of Combination of Anti-PD1 Antibody-activated TILs and Chemotherapy in Colorectal Cancer

M14AFS

Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer

A Phase 1/2a Study to Assess the Safety and Efficacy of CKD-516 Tab. in Combination With Irinotecan Inj.

Study of DC-CTL Combined With CIK for Advanced Solid Tumor

CAR-T Cell Immunotherapy in MUC1 Positive Solid Tumor

CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor

A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors

Limiting Chemotherapy Side Effects by Using Moxa

Single-port Versus Conventional Laparoscopic Colorectal Surgery

Safety and Efficacy Study of DCVax-Direct in Solid Tumors

OXY1A

Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer

NB1011 in Treating Patients With Metastatic or Recurrent Colorectal Cancer

Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer

TEXO

Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With Irinotecan

A Study of Picoplatin in Colorectal Cancer

Phase I/II Study of SOL for Untreated Metastatic Colorectal Cancer

Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Immunotherapy for Colorectal Cancers Using CEA-Pulsed Dendritic Cells and Subsequent IL-2 Treatment

A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies

Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies